Abstract:Background and aim: Hypoxia invariably develops as solid tumors enlarge, and there are unique cellular adaptations to ensure tumor survival in these conditions.Our previous work demonstrated a key role for K-RAS in the induction of angiogenic factors VEGF and IL-8 in hypoxic conditions.We have identified adrenomedullin (ADM) as a novel target of K-RAS in hypoxia and sought to determine its functional role in CRC.Methods: We performed cDNA microarray studies using DKS-5 cells with a K-RAS (D13) mutation and DKO-3 cells in which the mutant K-RAS oncogene was knocked-out.ADM expression was verified by Q-PCR and ELISA in CRC cells by knocking-down or overexpressing mutant K-RAS.ADM expression in 56 human colorectal tumors (K-RAS mutant=14, WT=42) was evaluated by immunohistochemistry.The functional roles on cell migration, invasion, and proliferation were determined after exogenous administration of ADM peptide or siRNA knockdown of ADM In Vitro.Results: Microarrays demonstrated that ADM was significantly upregulated in mutant K-RAS (D13) cells relative to isogenic WT K-RAS cells in hypoxic conditions.qPCR and ELISA assays confirmed the induction of ADM mRNA (17 fold) and protein (4.5 fold) by the combination of K-RAS and hypoxia.The hypoxic induction of ADM was reduced 70-89% when K-RAS was knocked-down in DLD1, HCT116, and SW480 cell lines.Stable expression of mutant K-RAS in Caco2 cells induced ADM expression 2.4 fold.The induction of ADM by K-RAS and hypoxia depended upon HIF-1, as this induction was blocked by knockdown of HIF-1alpha.In addition, inhibition of PI3K but not MEK1 suppressed the induction both HIF-1 and ADM in hypoxic conditions.Administration of 200 nmol/L ADM stimulated migration (217% ± 42%, p<0.001), invasion (195% ± 4.0%, p<0.001) and proliferation (146% ± 6.0%, p<0.01) of SW480 cells.Interestingly, ADM induced VEGF levels 1.5 fold, and knockdown of ADM suppressed VEGF levels to 32% of baseline.Finally, a significant correlation was observed between ADM protein staining and the K-RAS genotype in human CRC samples, with moderate to strong staining of ADM seen in 71% of K-RAS mutant tumors vs. 40% of K-RAS WT tumors (p<0.05).Conclusion: Adrenomedullin is a novel target of K-RAS and hypoxia in colon cancer.K-RAS regulates the hypoxic induction of ADM through the PI3K and HIF-1 pathways.In addition to stimulating colon cancer cell invasion and growth, ADM can regulate angiogenesis through the induction of VEGF.Collectively, these findings highlight the importance of K-RAS and ADM in colon tumor survival in hypoxic conditions.

Vinblastine inhibits the angiogenic response induced by adrenomedullin in vitro and in vivo

Adrenomedullin is a Novel K-RAS Target Gene That Regulates Cellular Invasion and Angiogenesis in Hypoxia

Adrenomedullin blockade induces regression of tumor neovessels through interference with vascular endothelial-cadherin signalling

Total and Not Bevacizumab-Bound Vascular Endothelial Growth Factor As Potential Predictive Factors to Bevacizumab-Based Chemotherapy in Colorectal Cancer.

Experiment of Vinorelbine or Combined with Hyperthermia on Inhibiting Angiogenesis

Induction of Drug-Resistance and Production of a Culture Medium Able to Induce Drug-Resistance in Vinblastine Untreated Murine Myeloma Cells

Effects of adrenomedullin on endothelial cells in the multistep process of angiogenesis: involvement of CRLR/RAMP2 and CRLR/RAMP3 receptors

Adrenomedullin in the growth modulation and differentiation of acute myeloid leukemia cells

[Anti-Angiogenic Effect of Vinorelbine in Combination with Cetuximab in Vitro and in Vivo].

Impact of Anti-Angiogenic Treatment on Bone Vascularization in a Murine Model of Breast Cancer Bone Metastasis Using Synchrotron Radiation Micro-CT

Targeting Adrenomedullin in Oncology: A Feasible Strategy With Potential as Much More Than an Alternative Anti-Angiogenic Therapy

The ADMR receptor mediates the effects of adrenomedullin on pancreatic cancer cells and on cells of the tumor microenvironment

Adrenomedullin gene dosage correlates with tumor and lymph node lymphangiogenesis

Interaction of CCN1 with αvβ3 integrin induces P-glycoprotein and confers vinblastine resistance in renal cell carcinoma cells.

Pharmacological effects of vinorelbine in combination with lenvatinib in anaplastic thyroid cancer

Effects of Adrenomedullin on Vascular Calcification in Rats

Vinblastine Resistance Is Associated with Nephronophthisis 3-Mediated Primary Cilia via Intraflagellar Transport Protein 88 and Apoptosis-Antagonizing Transcription Factor

The Potential of Antiangiogenic Therapy in Non–Small Cell Lung Cancer

Adrenomedullin(27–52) Inhibits Vascular Calcification in Rats

Transcriptomic and Functional Pathway Analysis of Human Cervical Carcinoma Cancer Cells Response to Microtubule Inhibitor

Does Vinblastine Retain its Anticancer Effect in the Presence of Cyclodextrin? A Preliminary Study